AI In Telemedicine Market Size Expected To Surge From USD 19.4 Billion In 2024 To USD 156.7 Billion By 2033: Dimension Market Research

(MENAFN- GlobeNewsWire - Nasdaq) Advancements and Projections in the AI in Telemedicine Market: Insights, Trends, Opportunities, and Recent Developments

New York, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Market Overview

The global AI in telemedicine Market is expected to grow from USD 19.4 billion in 2024 to USD 156.7 billion by 2033, at a CAGR of 26.1% .
AI in telemedicine refers to the application of artificial intelligence technologies to support and enhance remote healthcare services. AI enhances remote diagnostics, personalized treatments, & real-time monitoring by analyzing data for accurate diagnoses and predictive analyses.

Tools like virtual assistants and chatbots streamline patient interactions, reducing wait times & improving access to care. The market's growth is driven by teleconsultation services & advancements in IT, especially AI's role in diagnostic accuracy and medical imaging.

Click to Request Sample Report and Drive Impactful Decisions:

The US AI in Telemedicine Market

In the U.S., the AI in telemedicine market is projected to reach USD 6.7 billion by 2024, expanding to USD 48.2 billion by 2033 with a CAGR of 24.5% .

The rising prevalence of chronic diseases, an aging population, and government initiatives promoting digital healthcare are key growth drivers. AI integration in wearable devices and remote monitoring tools further enhances diagnostics and treatment plans.

Important Insights

• Market Growth: The global AI in telemedicine Market is forecasted to grow by USD 132.7 billion between 2025 and 2033, with a CAGR of 26.1% .
• Product Type: Software is projected to lead the AI in telemedicine market by product type, accounting for 60.2% of revenue in 2024.
• Application Analysis: Virtual nursing assistants are expected to secure a significant 26.4% share of market revenue by the end of 2024.
• End User Analysis: Homecare is anticipated to hold the largest revenue share, at 48.5% , in 2024.
• Regional Analysis: North America is expected to dominate the global AI in telemedicine market, with a 41.2% market share by 2024.

Latest Trends

• Integration of Advanced AI Technologies: The use of machine learning, NLP, & computer vision in telemedicine platforms enhances diagnosis accuracy by analyzing medical data in real time, leading to better patient outcomes & personalized treatments.
• Real-Time Data Insights: AI technologies provide real-time insights by processing large datasets like medical imaging & patient records, improving the quality of remote healthcare services.
• Cloud-Based and Edge AI Adoption: Cloud & edge AI are increasingly used in telemedicine for faster data processing, scalability, and real-time decision-making, allowing healthcare providers to deliver quicker responses.

Competitive Landscape

• Market Growth: The global AI in telemedicine market is highly competitive, with both large and small companies offering software and services across domestic and international markets.
• Market Fragmentation: The market is moderately fragmented, trending towards further fragmentation as more companies, including independent ventures, enter the space.
• Key Players: Major companies like Siemens Healthcare GmbH, IBM, and Cisco Systems Inc. are leading the market with steady growth driven by technological advancements and rising healthcare costs.
• Innovation from Independent Ventures: Young, independent ventures are driving innovation by offering specialized services and targeting specific population segments or medical conditions.

Some of the prominent market players:

• Siemens Healthcare GmbH
• Lifesize
• LEMONAID HEALTH INC.
• Koninklijke Philips N.V.
• IBM
• Hologic, Inc.
• HealthTap, Inc.
• Cisco Systems, Inc.
• CAE Healthcare Inc.
• Ricoh USA
• Altivity
• Ada Health GmbH
• Other Key Players

Transform your business approach with strategic insights from our report. Get in touch to request our brochure today! :

Global AI in Telemedicine Market Scope

Report Highlights	Details
Market Size (2023)	USD 19.4 Bn
Forecast Value (2033)	USD 156.7 Bn
CAGR (2024-2033)	26.1%
North America Revenue Share	41.2%
The US Market Size (2024)	USD 6.7 Bn
Historical Data	2018 - 2023
Forecast Data	2025 - 2033
Base Year	2023
Estimate Year	2024
Segments Covered	By Product Type, By Application, By End User
Regional Coverage	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Drivers

• Increased Demand for Remote Monitoring: An aging population and rise in chronic diseases drive demand for AI-driven telemedicine, improving access through virtual consultations and nursing, optimizing healthcare delivery.
• Streamlined Pre-Diagnosis: AI enhances telemedicine platforms by streamlining the pre-diagnosis process, boosting efficiency, and expanding market growth.
• Technological Advancements: Innovations in remote monitoring devices support AI integration, enabling real-time data collection and analysis of vital signs like heart rate and glucose levels.

Restraints

• Operational Complexities: The expansion of telemedicine services brings operational challenges, including coordinating healthcare providers, patients, and technology, which can hinder efficient scaling.
• Data Security Risks: The reliance on digital platforms for medical consultations raises data security risks, requiring strong safeguards against unauthorized access.

Opportunities

• Enhanced Diagnostic Accuracy: AI analyzes extensive medical data to detect diseases early, even in remote areas, leading to more accurate diagnoses and faster, more effective treatments.
• Streamlined Efficiency: AI technologies streamline operational tasks, reduce human error, and optimize workflows, allowing for more efficient management of administrative and data-related duties.
• Cost Reduction: AI-driven solutions lower costs and enable better allocation of resources toward patient care, making telemedicine services more scalable and fostering market growth.

Market Analysis

Virtual nursing assistants are expected to capture 26.4% of revenue share for AI in telemedicine market by the end of 2024, owing to their ability to make applications more accessible.

Telemedicine users, particularly the elderly and those in remote areas with limited healthcare access, often find it difficult to navigate complex telemedicine platforms. AI-powered virtual nursing assistants help address this by providing a user-friendly interface that simplifies access to medical care remotely.

These assistants enable users to easily retrieve medical records, receive personalized treatment plans, and connect with qualified physicians from the comfort of their homes which is a benefit especially valued by those less familiar with modern healthcare technology.

Purchase the Competition Analysis Dashboard Today:

AI in Telemedicine Market Segmentation

By Product Type

• Software
• Services

By Application

• Virtual Nursing Assistant
• Remote Monitoring & Predictive Analysis
• Diagnostics & Medical Imaging
• Medication Adherence & Treatment Plans
• Teleconsultation Enhancement
• Others

By End User

• Homecare
• Healthcare Facilities
• Others

Regional Analysis

North America is projected to dominate the AI in Telemedicine Market, holding a 41.2% revenue share by 2024, driven by its advanced technological infrastructure that supports the development & adoption of AI solutions in healthcare. The region has the major players as well as new entrants that are striving to implement AI across the segments of telemedicine among others.

Government bodies including the U.S Food and Drug Administration (FDA) and Health Canada have developed clear structures and policies on the use of Artificial Intelligence in Healthcare that is safe & efficient. These regulations promote the development of AI-based solutions while at the same time protecting the interest of patients which is paramount for the telemedicine solutions.

Click to Request Sample Report and Drive Impactful Decisions:

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA

Browse More Related Reports

• Disposable Conductive Tips Market is projected to reach USD 220.8 million by the end of 2024 and is anticipated to grow to USD 296.4 million in 2033 at a CAGR of 3.3%.
• Prosthetics And Orthotics Market size was valued at USD 7.32 Bn in 2024 and it is further anticipated to reach a market value of USD 11.07 Bn in 2033 at a CAGR of 4.7%.
• Colonoscopy Market size was valued at USD 4.3 Bn in 2024 and it is further anticipated to reach a market value of USD 6.8 Bn in 2033 at a CAGR of 5.1%.
• Digital Dentistry Market size was valued at USD 9.1 Bn in 2023 and it is further anticipated to reach a market value of USD 24.2 Bn in 2033 at a CAGR of 11.5%.
• Non-Invasive Glucose Meter Market size is expected to reach a value of USD 207.0 million in 2024, and it is further anticipated to reach a market value of USD 449.0 million by 2033 at a CAGR of 9.0%.
• Drug-Device Combination Products Market size is expected to reach a value of USD 174.4 billion in 2024, and it is further anticipated to reach a market value of USD 389.7 billion by 2033 at a CAGR of 9.3%.
• Operating Room Equipment & Supplies Market size is expected to reach a value of USD 52.8 billion in 2024, and it is further anticipated to reach a market value of USD 102.7 billion by 2033 at a CAGR of 7.7%.
• Wearable Activity Tracker Market size is expected to reach a value of USD 76.1 billion in 2024, and it is further anticipated to reach a market value of USD 258.0 billion by 2033 at a CAGR of 14.5%.
• Western Blotting Market size is expected to reach a value of USD 1,455.4 million in 2024, as it is an important technique that is used in life science experiments and it is further anticipated to reach a market value of USD 2,620.2 million by 2033 at a CAGR of 6.8%.
• Orthopedic Regenerative Surgical Products Market size is expected to reach a value of USD 4.5 billion in 2024, and it is further anticipated to reach a market value of USD 6.6 billion by 2033 at a CAGR of 4.4%.

Recent Developments

• June 2024: Wheel, a telehealth technology platform, introduced Horizon, an AI-driven solution designed to provide insights into patient care and alleviate the burden on healthcare providers. Horizon integrates data from patient profiles, lab results, previous case notes, and remote monitoring to make clinically relevant recommendations. Additionally, it helps providers detect trends across the platform, according to the company.
• August 2023: GE HealthCare received FDA approval for its Portrait Mobile, a wireless and wearable monitoring device. This solution allows patients to move freely while continuously tracking vital signs, including precise metrics such as respiratory rate.
• May 2023: AMC Health partnered with the University of Mississippi Medical Center to improve outcomes for patients with chronic illnesses. This collaboration contributes to the growth of the telemedicine market and facilitates the development of broader patient care systems outside traditional hospital settings.
• August 2022: AMC Health teamed up with Magnolia Regional Health Center (MRHC) to provide telehealth services for patients with conditions like CHF, COPD, diabetes, and hypertension. This partnership is expected to drive the expansion of telemedicine services.
• October 2022: AMC Health ended its joint venture with GE HealthCare, which aimed to combine AMC Health's Remote Patient Monitoring suite with GE HealthCare's clinical monitoring platform to extend patient care beyond hospital boundaries.
• March 2022: Microsoft's acquisition of Nuance, an AI and speech recognition software leader, underscored the industry's focus on innovation. The USD 19.7 billion seeks to improve patient engagement and operational insights through Microsoft Cloud for Healthcare.

About Dimension Market Research (DMR) :

Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts into work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world. We also believe that our clients don't always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.

CONTACT: United States 957 Route 33, Suite 12 #308 Hamilton Square, NJ-08690 Phone No.: +1 732 369 9777, +91 88267 74855 ...

MENAFN13112024004107003653ID1108882161